Company
Vivet Therapeutics
Vivet Therapeutics is developing novel and long-lasting gene therapies for rare inherited liver metabolic disorders
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Paris, France
- vivet-therapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Vivet Therapeutics is a clinical-stage emerging biotechnology company developing novel gene therapy treatments for rare, inherited metabolic diseases.
Funding snapshot
- Latest round
- Grant2024-02-01
Funding rounds
- Grant
- 2024-02-01
Loading relationship preview